Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer
Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combination of TS-1 and concurrent and
short-course radiotherapy is feasible in metastatic pancreatic cancer. The rationale of this
study primarily bases on the good efficacy of gemcitabine plus TS-1 and the great potential
of local control of concurrent chemoradiotherapy in pancreatic cancer.